02.01.2025 14:44:38

Lexicon Appoints Scott Coiante As CFO, SVP

(RTTNews) - Lexicon Pharmaceuticals, Inc. (LXRX), a biopharmaceutical company, Thursday announced the appointment of Scott Coiante as chief financial officer and senior vice president, with effect from January 2.

Coiante has 35 years of experience in the science and pharmaceutical industries and joins Lexicon from Agile Therapeutics, where he worked as the senior vice president, chief financial officer, and treasurer.

Tuesday, LXRX had closed 2.63% higher at $0.73 on the Nasdaq.

Analysen zu Lexicon Pharmaceuticals Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Lexicon Pharmaceuticals Inc 0,77 -10,86% Lexicon Pharmaceuticals Inc